Sivik Global Healthcare LLC Has $6.60 Million Position in Humana Inc. $HUM

Sivik Global Healthcare LLC boosted its holdings in Humana Inc. (NYSE:HUM) by 17.4% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 27,000 shares of the insurance provider’s stock after acquiring an additional 4,000 shares during the quarter. Humana accounts for about 1.8% of Sivik Global Healthcare LLC’s holdings, making the stock its 15th biggest position. Sivik Global Healthcare LLC’s holdings in Humana were worth $6,601,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Janney Montgomery Scott LLC acquired a new stake in Humana in the 1st quarter valued at $1,309,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Humana by 16.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock worth $300,728,000 after acquiring an additional 158,528 shares during the last quarter. Focus Partners Wealth boosted its holdings in Humana by 104.2% during the 1st quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock worth $1,701,000 after acquiring an additional 3,281 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in Humana by 2.4% during the 1st quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider’s stock worth $33,256,000 after acquiring an additional 2,950 shares during the last quarter. Finally, Circle Wealth Management LLC purchased a new position in Humana during the 1st quarter worth $425,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on HUM shares. Royal Bank Of Canada lifted their price objective on shares of Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a report on Thursday, August 21st. Sanford C. Bernstein lifted their price objective on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Piper Sandler cut their price objective on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Wells Fargo & Company lifted their price objective on shares of Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a report on Tuesday. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Wednesday. Seven equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $298.00.

Humana Trading Down 3.6%

NYSE HUM opened at $280.24 on Friday. The stock has a market capitalization of $33.70 billion, a price-to-earnings ratio of 21.51, a PEG ratio of 1.65 and a beta of 0.42. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The business’s fifty day moving average is $279.45 and its 200-day moving average is $258.13.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana’s payout ratio is currently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.